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Fine-tuning of the pluripotency program is executed by a multitude of cellular processes. Two recent studies
published in Cell Stem Cell (Wang et al., 2013; Tahmasebi et al., 2014) provide novel insights into the post-
transcriptional and translational regulatory mechanisms controlling stem cell pluripotency and somatic cell
reprogramming.In the past several years, a plethora of
work has been directed toward dissecting
the molecular mechanisms governing the
establishment and maintenance of the
pluripotent state. It is well known that pro-
tein-protein and protein-DNA interac-
tions, as well as specific miRNAs and
posttranslational modifications of core
transcription factors, can exert potent
control over the pluripotency program by
promoting protein degradation or by
blocking translation (Fabian et al., 2010).
However, significantly less is known
about potential regulatory mechanisms
that may control core pluripotency factor
gene expression at the posttranscrip-
tional and translational levels. Two recent
papers in Cell Stem Cell, Wang et al.
(2013) and Tahmasebi et al. (2014), pro-
vide insights into posttranscriptional and
translational regulation of pluripotency
genes, as well as key cell cycle regulators,
demonstrating that these processes are
essential for promoting pluripotency and
blocking differentiation.
Wang, Hu, and colleagues (Wang et al.,
2013) identified a posttranscriptional
mechanism that regulates pluripotency
and differentiation as well as somatic cell
reprogramming, in which nuclear export
of pluripotency gene mRNAs is positively
coupled to their expression. This is coor-
dinated by the THO/TREX (transcription/
export) complex, which functionally links
mRNA biogenesis to the nuclear export
of mature transcripts (Katahira, 2012). A
previous report from Hu and colleagues
identified Thoc5 in a genome-wide siRNA
screen for embryonic stem cell (ESC) self-
renewal factors (Hu et al., 2009), whereas
Thoc2 was discovered in a similar fashionthrough a genome-wide RNAi screen for
regulators of ESC identity (Ding et al.,
2009). Thoc2 and Thoc5 are members of
the THO/TREX complex, and Wang and
colleagues found that the expression pat-
terns of Thoc2 and Thoc5 paralleled that
of Oct4 before and after ESC differentia-
tion. Knockdown of Thoc2 or Thoc5
caused ESC differentiation, confirming
the requirement of both factors for ESC
maintenance (Wang et al., 2013). Remark-
ably, although loss of Thoc2 or Thoc5
caused a significant reduction in protein
expression of the pluripotency factors
Nanog, Sox2, Klf4, and Esrrb, their
mRNA levels remained relatively un-
changed. Such discordant expression be-
tween mRNA and protein levels has been
previously described at a systems level
during cell fate change of mouse ESCs
upon Nanog depletion (Lu et al., 2009)
and demonstrates the multilayered nature
of gene expression regulation in pluripo-
tent cells.
The authors then observed nuclear
retention of Nanog, Sox2, Klf4, and Esrrb
transcripts in Thoc2 and Thoc5 knock-
down ESCs, indicating a failure of the
THO complex to export these transcripts
out of the nucleus for translation. Interest-
ingly, they further found that depletion of
Thoc5 led to a drastic reduction in the
amounts of Nanog, Sox2, Klf4, and Esrrb
transcripts bound to Thoc2 (Wang et al.,
2013). Collectively, these data demon-
strate the critical role of the THO complex
in properly directing key pluripotency
transcripts for export from the nuclear
transcriptional apparatus toward the
cytoplasmic translation machinery in a
Thoc5-dependent manner (Figure 1).Cell Stem CeTahmasebi, Sonenberg, andcolleagues
investigated the role of mRNA transla-
tional control during the process of
reprogramming mouse embryonic fibro-
blasts (MEFs) to induced pluripotent
stem cells (iPSCs) with ‘‘Yamanaka fac-
tors’’ (Tahmasebi et al., 2014). It was pre-
viously shown that human fibroblasts can
be efficiently reprogrammed via transfec-
tion of synthetic reprogramming factor
mRNAs containing a 50 cap analog to
enhance translation efficiency, suggest-
ing a significant role of translational con-
trol in reprogramming (Warren et al.,
2010). The eukaryotic initiation factor 4F
(eIF4F) complex broadly controls protein
translation, including a specific subset
of mRNAs encoding genes involved in
proliferation. This process is tightly regu-
lated in self-renewing ESCs, and during
differentiation, ESCs undergo a wide-
spread increase in transcript abundance
and translation initiation (Sampath et al.,
2008). These findings prompted Tahma-
sebi and colleagues to determine whether
an inversely correlated regulation of trans-
lation could be observed during somatic
cell reprogramming.
eIF4E binding proteins (4E-BPs) are key
regulators of translation, and activated,
dephosphorylated 4E-BPs bind and in-
hibit the mRNA 50 cap binding factor
eIF4E to repress translation. These au-
thors found that phosphorylation levels
of 4E-BPs were much lower in pluripotent
cells compared to MEFs, consistent with
tight regulation of protein translation in
ESCs. Knockdown of 4E-BPs 1 and 2
significantly lowered reprogramming ef-
ficiency (Tahmasebi et al., 2014). The
importance of 4E-BPs in reprogrammingll 14, May 1, 2014 ª2014 Elsevier Inc. 549
Figure 1. Posttranscriptional and Translational Regulation of Pluripotency Gene Expression
ESCs express high levels of pluripotency factors whose transcripts are exported by the THO complex in a Thoc5-dependentmanner. Thoc2 and Thoc5 are down-
regulated during ESC differentiation, thereby compromising the export of pluripotency factor mRNAs, and eventually leading to the loss of the pluripotency gene
expression program. The eIF4F complex recognizes and binds the 50 cap of mRNAs via eIF4E to initiate translation. The p53/p21 pathway serves as a major
roadblock for efficient somatic cell reprogramming, and eIF4E-BPs are essential for this process by blocking the eIF4E-mediated translation of p21 transcripts.
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4E-BP1/2 double knockout (DKO) MEFs,
which displayed a similar inefficiency.
Because the p53/p21 pathway acts as a
barrier for efficient reprogramming (Hong
et al., 2009), Tahmasebi and colleagues
checked the expression levels of p53 and
p21 in wild-type and DKO MEFs. They
found that both p53 (a direct activator of
p21) and p21 protein levels, but not
mRNA levels, were increased,which could
explain the reprogramming defect ob-
served upon removal of 4E-BPs. These re-
sults suggested that 4E-BPs were directly
suppressing the translation of p21 tran-
scripts and that removing 4E-BPs during
reprogramming effectively derepressed
the expression of p21.
To test this hypothesis, the authors
removed this barrier from their system by
knocking out p53 in their DKO MEFs,
generating triple knockout (TKO) MEFs
(DKO + p53 KO). Infection of TKO MEFs
with Yamanaka factors not only rescued
the loss of reprogramming efficiency
observed in DKO MEFs, but also signifi-
cantly enhanced reprogramming effi-
ciency above that of wild-type and p53
KO MEFs. These results demonstrated
that 4E-BPs were critical for efficient re-
programming by blocking the translation
of p21 mRNA transcripts (Figure 1). Next,
the authors showed that Oct4 expression
alone was sufficient to reprogram TKO
MEFs due to increased translation of
Sox2 and c-Myc transcripts; this effect
was not observed in p53 KO MEFs
(Tahmasebi et al., 2014). They further550 Cell Stem Cell 14, May 1, 2014 ª2014 Elcharacterized Oct4-induced TKO iPSCs
and found that they were fully reprog-
rammed, as demonstrated by their multili-
neage differentiation in teratoma assays,
their ability to contribute to chimeric ani-
mals, and their competency to support
germline transmission. This work sheds
light on translational control during the
establishment of pluripotency and also
connects this critical layer of regulation
to the p53/p21 signaling pathway, a well-
known roadblock during reprogramming.
Wang et al. (2013) and Tahmasebi et al.
(2014) provide valuable insights into the
regulatory processes that occur down-
stream of transcriptional activation of plu-
ripotency genes, yet additional questions
remain. For instance, posttranscriptional
mechanisms controlling Oct4 expression
remain unclear. Oct4 nuclear export was
unaffected by loss of either Thoc2 or
Thoc5 (Wang et al., 2013), and expression
of Oct4 alone was sufficient to reprogram
4E-BP1/2 and p53 TKOMEFs (Tahmasebi
et al., 2014).Delineating the specificmech-
anisms that control Oct4 processing at the
posttranscriptional and translational levels
may reveal novel mechanisms of gene
regulation. It will also be beneficial to iden-
tify other eIF4E-sensitive genes, as these
may point to uniquemodes of pluripotency
control. Additional work is needed to eluci-
date downstream mechanisms within the
hierarchy of gene activation, which will
aid in designing more efficient reprogram-
ming strategies. Finally, a thorough exam-
ination of genome-wide cross-talk be-
tween transcription and translation willsevier Inc.certainly lead to many more new and
important insights, creating a better under-
standing of the molecular mechanisms
underlying stem cell pluripotency and so-
matic cell reprogramming.
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